The U.S. might soon see an approved respiratory syncytial virus vaccine for adults younger than 60.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
RSV vaccine is safe for young, middle-aged adults: Pfizer
The U.S. might soon see an approved respiratory syncytial virus vaccine for adults younger than 60.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis